posted on 2014-01-06, 00:00authored byAngela Mohs, Alexandre Ambrogelly, Xiaoyu Yang, Mark Haverick, Jason K. Cheung, Chakravarthy Narasimhan, Mohammed Shameem
Pegylation
of therapeutic proteins is an established technology used to enhance
the bioavailability of an active pharmaceutical ingredient in the
body of patients. While the physiochemical properties of pegylated
monomeric proteins have been extensively described, there is still
limited information on the characterization of pegylated oligomeric
proteins. In this study, we report the characterization of a pegylated
interferon alpha2b (PEGIFN-α2b) concentration-dependent oligomerization
by a series of orthogonal biochemical and biophysical methods. These
methods include sedimentation velocity and sedimentation equilibrium
analytical ultracentrifugation, matrix-assisted laser desorption ionization,
and size exclusion chromatography of bissulfosuccinimidyl suberate
cross-linked PEGIFN. We report here that PEGIFN-α2b self-associates
in a concentration-dependent manner into mainly monomers, dimers,
and trimers. In the presence of the chemical cross-linker, PEGIFN-α2b
is primarily monomeric (57%) at concentration lower than 0.3 mg/mL
and contains about equal amount of monomers and dimers (47.0% and
37.7%, respectively), about 15% of trimers, and up to 4% of higher
molecular weight species at 0.7 mg/mL and above.